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Asthma is a pulmonary disorder in which epi-
sodic dyspnea is caused by reversible bron-
chospasm (Steel and Holgate, 2001). Increased 
susceptibility to bronchospasm presumably re-
sults from qualitative and/or quantitative in-
creases in the contractility of airway smooth 
muscle. Increased contractility could result from 
changes intrinsic to smooth muscle (increases in 
the  number,  size,  and/or  responsiveness  of 
smooth muscle cells to stimuli that induce con-
traction) or from changes in other cell types 
such as neural cells, infiltrating inflammatory cells 
and epithelial cells that produce stimuli that pro-
mote smooth muscle contractility. In human asth-
matics and animals with experimental allergic 
airway disease, the predisposition to bronchospasm 
is manifested as airway hyperresponsiveness 
(AHR;  Steel  and  Holgate,  2001;  Lewkowich 
and Wills-Karp, 2008), an increased sensitivity 
to agents such as acetylcholine and methacho-
line, which induce smooth muscle contraction 
in normal individuals.
Studies with mouse models of allergic air-
way disease indicate that the development and 
maintenance of AHR depend on Th2 cyto-
kines, particularly IL-13 and to a lesser extent 
IL-4  (Grünig  et  al.,  1998; Wills-Karp  et  al., 
1998; Perkins et al., 2006), and on the ability of 
these cytokines to activate the transcription fac-
tor Stat6 by signaling through the type 2 IL-4R 
(Kuperman et al., 1998). Increased IL-4 and IL-13 
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Production of the cytokines IL-4 and IL-13 is increased in both human asthma and mouse 
asthma models, and Stat6 activation by the common IL-4/IL-13R drives most mouse model 
pathophysiology, including airway hyperresponsiveness (AHR). However, the precise cellular 
mechanisms through which IL-4R induces AHR remain unclear. Overzealous bronchial 
smooth muscle constriction is thought to underlie AHR in human asthma, but the smooth 
muscle contribution to AHR has never been directly assessed. Furthermore, differences in 
mouse versus human airway anatomy and observations that selective IL-13 stimulation of 
Stat6 in airway epithelium induces murine AHR raise questions about the importance of 
direct IL-4R effects on smooth muscle in murine asthma models and the relevance of these 
models to human asthma. Using transgenic mice in which smooth muscle is the only cell 
type that expresses or fails to express IL-4R, we demonstrate that direct smooth muscle 
activation by IL-4, IL-13, or allergen is sufficient but not necessary to induce AHR. Five 
genes known to promote smooth muscle migration, proliferation, and contractility are 
activated by IL-13 in smooth muscle in vivo. These observations demonstrate that IL-4R 
promotes AHR through multiple mechanisms and provide a model for testing smooth  
muscle–directed asthma therapeutics.
© 2011 Perkins et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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in transgenic mice that express IL-4R only in smooth 
muscle, as well as a second set of mice that have selectively 
deleted IL-4R from smooth muscle. Our results demon-
strate that selective smooth muscle expression of IL-4R is 
sufficient for cytokine-dependent induction of AHR and that 
this occurs in the absence of pulmonary eosinophilia or 
goblet cell hyperplasia. Our results also identify molecular 
mechanisms by which IL-4R signaling may induce AHR 
by demonstrating that IL-13 inhalation by mice that express 
IL-4R in smooth muscle induces five genes already known 
to increase smooth muscle proliferation, migration, and con-
tractility. Finally, we confirm that direct smooth muscle re-
sponsiveness to IL-4/IL-13 is not required for induction of 
AHR by demonstrating that AHR develops, along with air-
way eosinophilia and goblet cell hyperplasia, in IL-13– and 
allergen-inoculated  mice  that  selectively  lack  IL-4R  on 
smooth muscle. These observations demonstrate that direct 
effects of IL-4 and IL-13 on smooth muscle are sufficient but 
not necessary for induction of AHR, provide a tool that can 
be used to study how effects of these cytokines on smooth 
muscle influence AHR in human asthma, and identify novel 
smooth muscle–associated targets for asthma therapy.
RESULTS
Generation of mice that selectively express IL-4R  
on smooth muscle cells
To determine whether IL-4R signaling restricted to smooth 
muscle cells can induce responses characteristic of murine al-
lergic airway disease, we produced mice that express a trans-
gene for IL-4R controlled by the smooth muscle–specific 
promoter SMP8 (see Materials and methods) and bred these   
mice for more than eight generations to BALB/c IL-4R– 
deficient  mice  (Mountford  et  al.,  2001)  to  produce  mice 
that expressed a single allele of the SMP8–IL-4R trans-
gene  and  two  null  alleles  for  the  normal  IL-4R  gene 
(IL-4R//SMP8–IL-4R+/).
Four  approaches  were  tried  to  determine  whether   
IL-4R//SMP8–IL-4R+/ mice express IL-4R only in 
smooth muscle. Staining tissue sections with a probe specific 
for IL-4R messenger RNA or with an anti–IL-4R mAb 
proved unsatisfactory because of a low signal to noise ratio. 
Instead, we prepared single cell suspensions of spleen cells, 
tracheal smooth muscle cells, lung macrophages, and tracheal 
epithelial cells from wild-type (IL-4R+/+) mice, IL-4R+/ 
mice, IL-4R/ mice, and IL-4R//SMP8–IL-4R+/ 
mice, stained these cells with TO-PRO-3 iodide (Invitrogen) 
to eliminate dead cells and with anti–IL-4R mAb, and ana-
lyzed IL-4R staining by flow cytometry. We observed greater 
staining of spleen cells and lung macrophages from IL-4R+/+ 
mice than IL-4R/ mice, with approximately half as much 
staining by spleen cells from IL-4R+/ mice (Fig. 1, A [top], 
B, and C). Spleen cells from IL-4R//SMP8–IL-4R+/ 
mice stained similarly to spleen cells from IL-4R/ mice 
(Fig. 1, A [top] and B). Tracheal smooth muscle cells from 
IL-4R+/+ mice stained approximately twice as brightly as 
tracheal smooth muscle cells from either IL-4R+/ or   
expression in human asthmatic lungs (Huang et al., 1995; 
Kotsimbos et al., 1996; Humbert et al., 1997), the association 
of specific IL-4R alleles with risk for atopic asthma (Rosa-
Rosa et al., 1999), and observations that inhalation of an IL-4R 
antagonist improves pulmonary function in human asthmatics 
(Wenzel et al., 2007) suggest that a similar pathophysiological 
process  is  involved  in  human  asthma.  However,  it  is  not 
known whether IL-4 and IL-13 induce AHR through direct 
effects on airway smooth muscle. Although IL-13 increases 
smooth muscle contractility when added to cultures of airway 
smooth muscle cells (Shore and Moore, 2002; Shore, 2004b), 
airway smooth muscle isolated from human asthmatics is not 
consistently hypercontractile (Wills-Karp, 1997). Furthermore, 
IL-13 induces AHR in transgenic mice that only express Stat6 
in pulmonary epithelial cells (Kuperman et al., 2002). These 
observations suggest that AHR might result from changes in 
the properties of airway epithelium such as increased swelling, 
permeability, rigidity, and mucus production that decrease air-
way diameter rather than from changes in smooth muscle. 
Alternatively, Stat6-mediated effects on epithelial cells could 
stimulate the production of mediators that affect airway 
smooth muscle.
Recent studies with mice that selectively lack IL-4R on 
smooth muscle are also consistent with the sufficiency of IL-4 
or IL-13 effects on airway epithelium for induction of AHR. 
Intraperitoneal immunization with ovalbumin bound to alum, 
followed by ovalbumin inhalation, induced AHR, goblet cell 
hyperplasia, and airway eosinophilia, as well as Th2 cytokine 
and IgE secretion, which were similar in mice that expressed 
IL-4R normally or that selectively deleted IL-4R from 
smooth muscle cells, whereas similar immunization of mice 
totally deficient in IL-4R failed to induce any of these ef-
fects  (Kirstein  et  al.,  2010). The  normal  responsiveness  of   
mice that selectively lacked smooth muscle IL-4R in this 
model was somewhat surprising, inasmuch as studies with the 
same mice demonstrated decreased Th2 cytokine expression 
and airway goblet cell hyperplasia after infection with the 
nematode parasite Nippostrongylus brasiliensis (Horsnell et al., 
2007, 2011).
These results were consistent with some analyses of pul-
monary function assays in rodents, which support the view 
that increased AHR in experimental models of allergic airway 
disease results predominantly from changes in epithelial rather 
than smooth muscle cells (Wagers et al., 2004); however, this 
view is not universal (Glaab et al., 2007). In fact, IL-4R–
mediated effects on epithelial cells are not likely to totally 
account for increased AHR because allergen inhalation still in-
duces AHR in mice in which the signaling IL-4R polypeptide, 
IL-4R, has been selectively deleted from airway epithelial 
cells (Kuperman et al., 2005). Collectively, the in vivo obser-
vations made with IL-4R and Stat6 transgenic mice suggest 
that IL-4R signaling induces AHR through direct effects on 
more than one cell type and leave open the possibility that 
AHR development is promoted by direct IL-4R signaling of 
smooth muscle cells. We have evaluated this possibility by ex-
amining the effects of IL-4, IL-13, and allergen immunization JEM VOL. 208, April 11, 2011 
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with B6.129 × 1-Gt(ROSA)26.Sortm1(EYFP)Cos/J mice (Rosa-
YFP mice; Druckenbrod and Epstein, 2005), in which YFP 
is produced by cells that express Cre, and evaluating frozen 
sections of lung, intestine, and liver for YFP expression by 
fluorescence  microscopy. YFP  expression  was  restricted  to 
smooth muscle cells in the lung (Fig. 1 E), small intestine, and 
artery (Fig. S1).
Effects of inhaled IL-13 and IL-4 on mice that selectively 
express IL-4R on smooth muscle
IL-4R+/, IL-4R/, and IL-4R//SMP8–IL-4R+/ 
mice were inoculated intratracheally (i.t.) with IL-13 or 
saline (2–3 µg/day for 7 d) and tested for responsiveness to 
cholinergic stimulation by noninvasive barometric plethysmog-
raphy, the invasive air pressure–time index (APTI) technique, 
IL-4R//SMP8–IL-4R+/ mice, and these stained more 
brightly than tracheal smooth muscle cells from IL-4R/ 
mice (Fig. 1, A [middle] and D). Tracheal epithelial cells from 
IL-4R//SMP8–IL-4R+/ mice stained no more brightly 
than tracheal epithelial cells from IL-4R/ mice and less 
brightly than tracheal epithelial cells from IL-4R+/ mice 
(Fig. 1 A, bottom). Thus, the SMP8–IL-4R transgene in-
duces approximately the same amount of IL-4R expression 
as the normal IL-4R gene on smooth muscle cells and does 
not induce IL-4R expression on spleen cells or on pulmo-
nary epithelial cells.
Because it was not possible to determine IL-4R expres-
sion on all cell types by immunofluorescence staining and 
flow cytometry, we investigated the specificity of the SMP8 
promoter for smooth muscle by breeding SMP8-Cre mice 
Figure 1.  Evaluation of IL-4R expression in IL-4R//SMP8–IL-4R+/ mice. (A) Expression of IL-4R by IL-4R+/+, IL-4R+/, IL-4R/, and 
IL-4R//SMP8–IL-4R+/ mice in spleen (top), tracheal smooth muscle cells (middle), or tracheal epithelial cells (bottom). Representative results of 
three to four replicate experiments with one mouse/group are shown. (B) IL-4R expression by CD45+CD3+ and CD45+CD3 spleen cells from mice of the 
indicated genotype. Single experiment with four mice/group. *, P < 0.05 by one-tailed Student’s t test compared with IL-4R/ spleen cells. (C) IL-4R 
expression by macrophages in lung digests from the indicated genotype. Macrophages were identified as CD45+CD11b+ cells that displayed light scatter 
characteristics typical for macrophages. Single experiment with four mice/group. *, P < 0.05 by one-tailed Student’s t test compared with lung macro-
phages from IL-4R/ mice. (D) IL-4R expression by tracheal smooth muscle cells from mice of the indicated genotype. Two experiments with two 
mice/group each. *, P < 0.05 by one-tailed Student’s t test compared with tracheal smooth muscle cells from IL-4R/ mice. (B–D) Error bars indicate 
SEs. (E) YFP (green) expression in smooth muscle cells in bronchioles (top) or alveoli (middle) in Rosa/SMP8-Cre+ lung. Arrows point to YFP+ cells. Lack of 
YFP (green) expression in bronchioles from control (Rosa/SMP8-Cre) lung (bottom) is also shown. Bars, 25 µm. (F) Comparison of IL-4R expression by 
tracheal smooth muscle cells from wild-type, SMP8-Cre/IL-4Rflox/, IL-4R/, and IL-4R//SMP8–IL-4R+/ mice. Histograms of IL-4R expression 
of cells from IL-4R/ mice are shown as purple-filled black lines in all three panels; histograms of IL-4R expression by cells from two individual  
IL-4Rflox//SMP8-Cre+/ mice (top), wild-type mice (middle), and IL-4R//SMP8–IL-4R+/ mice (bottom) are as red and green lines. Data are from 
one of the two experiments used to prepare the graph in D.856 Smooth muscle IL-4R–dependent AHR | Perkins et al.
i.t. inoculation of all three mouse strains with IL-4C (a long-
acting  form  of  IL-4)  also  stimulated  AHR  in  IL-4R+/,   
IL-4R+/+, and IL-4R//SMP8–IL-4R+/ mice but   
not IL-4R/ mice (Fig. 3, A–C). However, in contrast to 
IL-13, IL-4C had a greater effect on airway responsiveness in 
the IL-4R//SMP8–IL-4R+/ mice than in IL-4R+/ or 
even IL-4R+/+ mice. IL-4C inhalation induced some increase 
in airway responsiveness in IL-4R//SMP8–IL-4R+/ mice 
in as little as 24 h, as determined by barometric plethysmography, 
although greater effects at higher doses of methacholine were 
seen after 3 d (Fig. 3 D). IL-4C resembled IL-13 more closely in 
that it induced BAL fluid eosinophilia (Fig. 3 E) and goblet cell 
hyperplasia (Fig. 3 F) only in the mice that expressed a wild-type 
IL-4R allele. None of the IL-4C– or IL-13–inoculated mice 
showed convincing airway smooth muscle hyperplasia or hyper-
trophy by histological examination (unpublished data).
Effects of allergen inhalation  
on mice that selectively express  
IL-4R on smooth muscle
To determine whether AHR could be 
induced by endogenously produced 
IL-4/IL-13  in  IL-4R//SMP8–
IL-4R+/ mice, these mice as well   
as IL-4R+/ and IL-4R/ mice 
were inoculated i.t. thrice weekly for 
3 wk with dust mite allergen, which 
induces allergic airway disease in wild-
type  BALB/c  mice  without  a  re-
quirement for systemic priming with 
allergen plus adjuvant (Johnson et al., 
2004; Lewkowich et al., 2005). Dust 
mite  inoculation  induced  AHR  in 
IL-4R+/ mice but not in IL-4R/ 
mice,  as  determined  by  barometric 
and the invasive flexiVent technique (Fig. 2, A–C). Mice were 
then sacrificed, bronchoalveolar lavage (BAL) and BAL cell 
analysis were performed (Fig. 2 D), and lung sections were 
prepared and stained for goblet cells (Fig. 2 E). As expected, 
IL-13 had no detectable effects in IL-4R/ mice and in-
duced BAL eosinophilia and goblet cell hyperplasia only in 
the IL-4R+/ mice. Responsiveness to methacholine was 
somewhat  greater  in  saline-stimulated  IL-4R//SMP8–
IL-4R+/ mice than IL-4R+/ mice as measured by baro-
metric plethysmography but was similar as measured by the 
two invasive techniques. IL-13 inhalation increased airway re-
sponsiveness  in  both  IL-4R//SMP8–IL-4R+/  and 
IL-4R+/ mice but had a greater effect in the IL-4R+/ mice. 
This difference was observed with both the invasive and non-
invasive techniques but was most apparent when the invasive 
techniques were used.
Figure 2.  i.t. inoculation of IL-4R//
SMP8–IL-4R+/ mice with IL-13 induces 
AHR but not goblet cell hyperplasia or 
BAL fluid eosinophilia. (A–C) IL-4R+/,  
IL-4R/, and IL-4R//SMP8–IL-4R+/ 
mice were inoculated daily i.t. with saline or 2 or  
3 µg IL-13 for a consecutive 7 d and tested for 
responsiveness to methacholine by barometric 
plethysmography (A; three experiments, 
pooled data, n = 11–13/group), flexiVent  
(B; one experiment, n = 4–7/group), and APTI 
(C; one experiment, n = 3–5/group). (D) Num-
bers of BAL neutrophils, lymphocytes, macro-
phages, and eosinophils (three experiments, 
pooled data, n = 11–12/group). (E) Lung  
sections were PAS stained and evaluated  
for percentage of PAS+ bronchial epithelial 
cells (one of three experiments with similar 
results shown, n = 4–5/group). Error bars 
indicate SEs. *, P < 0.05 for IL-13 versus  
saline treatment.JEM VOL. 208, April 11, 2011 
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wild-type  BALB/c  mice  before  i.t. 
inoculation of the recipients with dust 
mite allergen. This protocol induced 
the  development  of AHR  in  both 
IL-4R+/  and  IL-4R//SMP8–
IL-4R+/ mice but not in IL-4R/ 
mice, as determined by barometric 
plethysmography,  flexiVent  analysis, 
and  APTI  (Fig.  5,  A  and  B).  Both  the  IL-4R/  and   
IL-4R//SMP8–IL-4R+/ recipients of allergen-primed 
wild-type bronchial lymph node cells developed more BAL 
eosinophilia and goblet cell hyperplasia than mice that were 
not immunized but considerably less than allergen-inoculated 
IL-4R+/ mice (Fig. 5, C and D), whereas most IL-4R+/ 
mice and some IL-4R//SMP8–IL-4R+/ mice developed 
increased serum IgE levels (Fig. 5 E).
IL-13 induction of pulmonary gene expression
These observations demonstrated that AHR can be induced 
through direct, in vivo effects of IL-4R signaling on smooth 
muscle and were consistent with previous in vitro evidence 
that IL-4R signaling can increase smooth muscle contractility 
(Laporte et al., 2001; Tliba et al., 2003; Shore, 2004b; Akiho   
et al., 2005; Kellner et al., 2007; Bossé et al., 2008; Farghaly   
et al., 2008; Martin et al., 2008; Ohta et al., 2008; Woodruff, 
2008). However, they offered no insight into the mechanisms 
through which IL-4R signaling induces these effects. To shed 
light on possible mechanisms, a comprehensive gene scan was 
performed to identify genes in lung whose expression was 
plethysmography and the APTI and flexiVent techniques 
(Fig. 4, A–C). In the IL-4R//SMP8–IL-4R+/ mice, 
dust mite allergen inoculation induced increased responsive-
ness to methacholine as measured by barometric plethysmog-
raphy (Fig. 4 A) but not as measured by APTI (Fig. 4 B), 
whereas flexiVent measurements suggested a slight but insig-
nificant increase in responsiveness (Fig. 4 C). As expected, dust 
mite inoculation also induced an IgE response in IL-4R+/ 
mice but not in IL-4R/ or IL-4R//SMP8–IL-4R+/ 
mice  (Fig.  4  D),  much  greater  eosinophil  responses  in   
IL-4R+/ mice than in IL-4R/ or IL-4R//SMP8–
IL-4R+/ mice (Fig. 4 E), and goblet cell responses only   
in IL-4R+/ mice (Fig. 4 F).
Because the failure of IL-4R//SMP8–IL-4R+/ mice 
to develop AHR as demonstrated by the invasive techniques 
might result from a poor IL-4/IL-13 response to dust mite al-
lergen by the IL-4R–deficient T cells in these mice (Fig. 4 G) 
rather than from the inability of their lung epithelial cells to 
respond to these cytokines, we performed an additional ex-
periment in which the same mouse strains were injected 
with bronchial lymph node cells from dust mite–immunized 
Figure 3.  i.t. inoculation of IL-4R//
SMP8–IL-4R+/ mice with IL-4C induces 
AHR but not goblet cell hyperplasia or 
BAL fluid eosinophilia. (A–C) IL-4R+/,  
IL-4R/, and IL-4R//SMP8–IL-4R+/ mice 
were inoculated daily i.t. with saline or IL-4C 
(2 µg IL-4 plus 10 µg BVD4-1D11) every other 
day for 7 d and tested for responsiveness to 
methacholine by barometric plethysmography 
(A; two pooled experiments, n = 8–10/group), 
flexiVent (B; one experiment, n = 4–8/group), 
and APTI (C; one experiment, n = 4/group).  
(D) In a separate experiment, IL-4R+/,  
IL-4R/, and IL-4R//SMP8–IL-4R+/ mice 
were inoculated daily with saline or IL-4C and 
evaluated by barometric plethysmography 1 d 
after the first and third inoculations for re-
sponsiveness to methacholine (two pooled 
experiments, n = 12/group). (E) Numbers of 
BAL neutrophils, lymphocytes, macrophages, 
and eosinophils (two pooled experiments,  
n = 8–9/group). (F) Lung sections were PAS 
stained and evaluated for percentage of PAS+ 
bronchial epithelial cells (two pooled experi-
ments, n = 8–9/group). Data shown in B and C 
are from independent experiments. Error bars 
indicate SEs. *, P < 0.05 for IL-4C versus  
saline treatment.858 Smooth muscle IL-4R–dependent AHR | Perkins et al.
inhaled IL-13 in IL-4R//SMP8–
IL-4R+/  but  not  in  IL-4R/ 
mice; however, this was not confirmed 
by real-time PCR (unpublished data). 
As expected, several genes known to 
be induced by IL-4R signaling in epi-
thelial  cells  and  macrophages  were 
strongly  induced  by  IL-13  inhala-
tion in IL-4R+/ mice but not in 
IL-4R/  or  IL-4R//SMP8–
IL-4R+/ mice (results are shown in 
Fig.  6 A  for  Itlnb  and  Sprr2a;  Arg, 
Muc5ac, Mmp12, Chi3l3, Retnlb, Chia, and Clca3 were also 
expressed at least 40-fold more in IL-4R+/ mice than in 
IL-4R//SMP8–IL-4R+/ mice that had inhaled IL-13). 
These observations suggest several potential mechanisms for 
induction of AHR by IL-4 and IL-13 and provide an inde-
pendent confirmation of the smooth muscle specificity of   
IL-4R expression in IL-4R//SMP8–IL-4R+/ mice.
To determine whether any of the five genes that were in-
duced by IL-13 in IL-4R//SMP8–IL-4R+/ mice are 
induced selectively in smooth muscle, we evaluated their ex-
pression, along with expression of Tnfrsf11, Itlnb, and Sprr2a in 
SMP8-Cre+//IL-4Rflox/ mice, which were designed to 
express IL-4R on all cell types except for smooth muscle 
(Fig. 1, B and D–F). As expected, IL-13 greatly up-regulated 
expression of Itlnb and Sprr2a in these mice (Fig. 6 B). IL-13 
also up-regulated expression of Timp1, Egln3, and Vcan in 
these mice, suggesting that these genes are up-regulated by 
IL-13 in nonsmooth muscle as well as smooth muscle cells.   
In  contrast,  Myocd  and  Rab39b  were  not  up-regulated  by   
increased or decreased by a factor >1.5 by IL-13 inhalation in 
IL-4R+/ and IL-4R//SMP8–IL-4R+/ mice but not 
in IL-4R–deficient mice. Results (GEO DataSets accession 
no. GSE26476), confirmed by real-time PCR, revealed five 
genes, Timp1, Egln3, Myocd, Vcan, and Rab39b, whose ex-
pression was significantly increased in IL-4R//SMP8–
IL-4R+/  mice  by  IL-13  inhalation  and  which  were 
expressed at a greater level in IL-13–inoculated IL-4R//
SMP8–IL-4R+/ mice than in IL-4R/ mice (Fig. 6 A, 
top six panels). Expression of a sixth gene, Tnfrsf11, which 
was originally identified by our gene scan, was significantly 
greater in IL-13–treated IL-4R//SMP8–IL-4R+/ than 
IL-4R/ mice but not significantly greater in IL-13–treated 
than  in  saline-treated  IL-4R//SMP8–IL-4R+/  mice 
(P = 0.07). Remarkably, all of these genes were already known 
to be expressed in smooth muscle and to contribute to smooth 
muscle cell differentiation, proliferation, contractility, and/or 
migration (Table I). An additional 12 genes were identified 
by gene scan to decrease lung expression in response to   
Figure 4.  Effect of i.t. allergen admin-
istration on IL-4R//SMP8–IL-4R+/ 
mice. (A–C) IL-4R+/, IL-4R/, and IL-
4R//SMP8–IL-4R+/ mice were inocu-
lated three times per week i.t. for 3 wk with 
saline or dust mite allergen and then tested 
for responsiveness to methacholine by 
barometric plethysmography (A; two pooled 
experiments, n = 9–12/group), flexiVent  
(B; two pooled experiments, n = 9–12/
group), and APTI (C; one separate experi-
ment, n = 4–6/group). (D) Serum IgE levels 
were determined by ELISA (two pooled 
experiments, n = 8–11/group). (E) Lung sec-
tions were PAS stained and evaluated for 
percentage of PAS+ bronchial epithelial cells 
(two pooled experiments, n = 9–11/group). 
(F) Numbers of BAL neutrophils, lympho-
cytes, macrophages, and eosinophils (two 
pooled experiments, n = 9–12/group).  
(G) Production of IL-4 and serum levels of 
IL-13–sIL-13R2 complexes (two pooled 
experiments, n = 11–14/group). Error bars 
indicate SEs. *, P < 0.05 for dust mite aller-
gen versus saline treatment.JEM VOL. 208, April 11, 2011 
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specifically delete IL-4R from smooth 
muscle and inoculated mice with ovalbu-
min rather than dust mite allergen or 
IL-13 (Kirstein et al., 2010). To indepen-
dently evaluate this issue, we compared 
the effects of IL-13 or dust mite allergen 
inhalation on the development of air-
way eosinophilia, goblet cell hyperplasia, 
and AHR in IL-4Rflox//SMP8-Cre+/ 
versus IL-4R+/ and IL-4R/ mice. 
AHR, in addition to airway eosinophilia and goblet cell hy-
perplasia, was induced by inhalation of either IL-13 or dust 
mite allergen in IL-4Rflox//SMP8-Cre+/ and IL-4R+/ 
mice but not in IL-4R/ mice (Figs. 7 and 8).
DISCUSSION
AHR, a hallmark of asthma and cause of asthma morbidity, is 
induced by IL-4 and IL-13 in mice and associated with the 
same cytokines in humans. Because IL-4/IL-13R expression 
is ubiquitous, AHR could, in theory, result from IL-4/IL-13 
effects on almost any cell type. Stimulation of lymphocytes, 
macrophages, mast cells, basophils, or dendritic cells, for ex-
ample, might induce production of vasoactive mediators that 
promote AHR through their effects on epithelial cells, neurons, 
or smooth muscle cells or induce production of chemokines 
that attract inflammatory cells whose activities induce AHR. 
IL-13 in these mice, even though they were up-regulated by 
IL-13  in  IL-4R+/  and  IL-4R//SMP8–IL-4R+/ 
mice (Figs. 6, A and B). This suggests that Myocd and Rab39b 
are selectively up-regulated by IL-13 in smooth muscle cells 
and makes them attractive potential therapeutic targets.
Expression of IL-4R by smooth muscle is not essential  
for induction of AHR by IL-13 or allergen
A previous study suggested that IL-4R expression by smooth 
muscle  should  not  be  essential  for  cytokine  induction  of 
AHR  by  demonstrating  that AHR  develops  in  mice  that 
overexpress IL-13 in their lungs and express Stat6, which is a 
transcription factor required for IL-4/IL-13–induced AHR, 
only in airway epithelium (Kuperman et al., 2002). This re-
sult was recently confirmed in a study that used the smooth 
muscle myosin heavy chain promoter rather than SMP8 to 
Figure 5.  Effect of i.t. allergen adminis-
tration on IL-4R//SMP8–IL-4R+/ mice 
reconstituted with IL-4R+/+ allergen– 
immune lymphoid cells. Wild-type BALB/c 
mice were immunized i.p. with dust mite aller-
gen adsorbed to alum once a week for 3 wk 
and then inoculated i.t. with dust mite allergen 
every other day for 18 d. (A and B) 5 × 106 
bronchial lymph node cells prepared from  
these mice were injected i.v. into IL-4R+/,  
IL-4R/, and IL-4R//SMP8–IL-4R+/ mice, 
which were then inoculated three times per 
week i.t. for 3 wk with saline or dust mite al-
lergen and tested for responsiveness to metha-
choline by barometric plethysmography (A; two 
pooled experiments, n = 8–12/group), flexiVent 
analysis (A; one experiment, n = 3–6/group), or 
APTI (B; one separate experiment, n = 3/group 
for saline and 5–6/group for house dust mite). 
(C) BAL was performed, and numbers of BAL 
neutrophils, lymphocytes, macrophages, and 
eosinophils were determined (two pooled ex-
periments, n = 6–11/group). (D) Lung sections 
were PAS stained and evaluated for percentage 
of PAS+ bronchial epithelial cells (two pooled 
experiments, n = 9–13/group). (E) Serum IgE 
levels were determined by ELISA (two pooled 
experiments, n = 5–13/group). Error bars indi-
cate SEs. *, P < 0.05 for dust mite allergen  
versus saline treatment.860 Smooth muscle IL-4R–dependent AHR | Perkins et al.
Although a previous study demonstrated that direct IL-13 
activation of Stat6 in airway epithelial cells induces AHR in 
mice (Kuperman et al., 2002) and AHR has been reported to 
depend on the products of epithelial cell–expressed genes that 
are induced by IL-4/IL-13 (Howarth et al., 1995; Goto et al., 
2000; Poynter et al., 2002; Zhu et al., 2004; Kawada et al., 
2007), a study that demonstrated that AHR still develops in 
allergen-inoculated mice that have selectively deleted IL-4R 
from airway epithelium (Kuperman et al., 2005) indicates that 
IL-4/IL-13 effects on other cell types must also be capable of 
inducing AHR. This justified consideration of smooth muscle, 
a cell type implicated in AHR by in vitro human and animal 
studies. These studies demonstrated that IL-13 increases the 
AHR-inducing effects of IL-4/IL-13 might also be direct. 
IL-4R stimulation of epithelial cells, which induces AHR in 
mice (Kuperman et al., 2002), dramatically changes the ex-
pression of multiple epithelial cell genes and induces air-
way goblet cell hyperplasia and increased mucus production, 
which could contribute to AHR by narrowing airways. IL-4R 
stimulation of neurons might increase production and/or 
facilitate  release  of  acetylcholine,  which  induces  smooth   
muscle contraction (Goldhill et al., 1997). IL-4R stimulation 
of smooth muscle cells might increase their contractility   
and/or stimulate them to proliferate or hypertrophy (Wills-
Karp, 1997; Laporte et al., 2001; Shore and Moore, 2002; 
Shore, 2004a).
Figure 6.  IL-13–induced pulmonary smooth muscle 
gene expression. (A) Mice of the indicated genotype 
were inoculated i.t. with normal saline or 3 µg IL-13 for a 
consecutive 7 d. Lung RNA was prepared and analyzed in 
an initial experiment by gene scan to identify genes that 
were increased at least twofold in IL-13– versus saline-
treated IL-4R//SMP8–IL-4R+/ mice and at least 
twofold in IL-13–treated IL-4R//SMP8–IL-4R+/ 
versus IL-4R/ mice and for genes that were expressed 
>10-fold more in IL-13–treated IL-4R+/ versus  
IL-4R//SMP8–IL-4R+/ mice (gene scan performed 
with two separate groups of four mice each for each 
genotype and treatment). Results of the gene scan were 
verified by real-time PCR with the same RNA samples 
and with RNA prepared from lungs from two additional 
experiments. Total of 18–22 mice for each genotype/
treatment group. To pool data from different experi-
ments, the mean value for each gene in the IL-4R+//
saline group in each experiment was given an arbitrary 
value of 1, and all individual values were adjusted ac-
cordingly. Geometric means and SEs were then deter-
mined. Log values were converted back to linear values 
for graphing. A one-tailed Student’s t test was used to 
test the hypotheses that IL-13 induced greater gene 
expression than saline in IL-4R//SMP8–IL-4R+/ 
mice and that IL-13 induced greater gene expression in 
IL-4R//SMP8–IL-4R+/ than in IL-4R/ mice. *,  
P < 0.05 for IL-13– versus saline-treated IL-4R//SMP8–
IL-4R+/ mice; †, P < 0.05 for IL-13–treated IL-4R//
SMP8–IL-4R+/ versus IL-4R/ mice. (B) Age- and 
sex-matched IL-4R+/, IL-4R/, and SMP8-Cre+//IL-
4Rflox/ mice were inoculated with saline or IL-13 as in 
A. RNA was prepared from their lungs and assayed for 
expression levels of the genes shown by real-time PCR. 
Data were pooled from two experiments with similar 
results (n = 13–14 mice/group). A one-tailed Student’s  
t test was used to compare gene expression in saline- 
versus IL-13–treated IL-4R//SMP8–IL-4R+/ mice 
and in IL-13–treated IL-4R+/ versus IL-4R/ and 
SMP8-Cre+//IL-4Rflox/ mice. *, P < 0.05 for IL-13– 
versus saline-treated IL-4R+/ or SMP8-Cre+//IL-
4Rflox/ mice; †, P < 0.05 for IL-13–treated 
SMP8-Cre+//IL-4Rflox/ versus IL-4R/ mice.JEM VOL. 208, April 11, 2011 
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Table I.  Pulmonary genes induced by i.t. IL-13 in IL-4R//SMP8–IL-4R+/ mice
Gene Alternate name Description Reference
Egln3 EGL nine homologue 3 A prolyl hydroxylase, involved in muscle differentiation, most highly 
expressed in muscle.
Fu et al., 2007
Vcan Versican, chondroitin 
sulfate glycoprotein 2 
(Cspg2)
A large chondroitin sulfate proteoglycan that is deposited in the airway 
smooth muscle layer in patients with asthma; promotes proliferation and 
migration of vascular smooth muscle cells.
Huang et al., 2006
Myocd Myocardin The dominant driver of smooth muscle differentiation and the smooth 
muscle contractile phenotype
Pipes et al., 2006
Rab39b Ras-related protein Rab 
39B
A member of the RAS oncogene family; small molecular weight GTPases 
that control vesicular trafficking. Ras family signaling is associated with 
differentiation, proliferation, and hypertrophy.
Sugden, 2003
Timp1 Tissue inhibitor of 
metalloproteinase 1
Expressed in dystrophic and regenerating muscle fibers, blocks  
extracellular matrix degradation.
Untergasser et al., 2005; Sun  
et al., 2006
Tnfrsf11b TNF receptor superfamily, 
member 11b, 
osteoprotegerin (OPG)
Produced by smooth muscle cells; stimulates proliferation and migration  
of pulmonary artery smooth muscle cells in vitro.
Lawrie et al., 2008
Figure 7.  IL-13 induces allergic airway disease in mice that selectively lack IL-4R in smooth muscle. (A, top) Mice of the indicated genotype 
were inoculated i.t. with saline or 3 µg IL-13 thrice weekly for 3 wk and then analyzed for AHR by barometric plethysmography (two pooled experiments, 
n = 6–14/group). (bottom) Mice were then inoculated with an additional dose of IL-13 and analyzed for AHR with a flexiVent apparatus (two pooled ex-
periments, n = 6–14/group). (B) BAL cell numbers and differential counts (one experiment, n = 7–8/group). (C) Percentage of PAS+ bronchial epithelial 
cells (one experiment, n = 7–8/group). Error bars indicate SEs. Asterisks indicate a significant increase (*, P < 0.05) for IL-13 versus saline treatment.862 Smooth muscle IL-4R–dependent AHR | Perkins et al.
IL-4 and IL-13 production was lim-
ited in the former strain by the ab-
sence of IL-4R on lymphoid cells. 
This  conclusion  is  supported  by   
the more impressive development of 
AHR in allergen-immunized smooth 
muscle–only mice that were inocu-
lated  with  allergen-primed  lymph 
node cells from wild-type mice before their own inoculation 
with allergen.
Our results also suggest that smooth muscle IL-4R signal-
ing increases AHR by increasing the expression of several 
genes that likely act in parallel to promote smooth muscle 
differentiation, proliferation, migration, and contractility and 
to promote the accumulation of extracellular matrix, which 
enhances smooth muscle contractility (Table I). Although the 
extent  to  which  these  changes  in  gene  expression  affect 
smooth muscle protein expression and the exact mechanisms 
by which changes in the expression of these genes promote 
AHR remain unknown, our observations provide useful leads 
for further investigation as well as potential targets for asthma 
therapy. It is also likely that IL-4R signaling increases or de-
creases the expression of additional genes in smooth muscle 
but that these changes are not seen in a whole lung analysis 
because they are obscured by IL-4R–independent expression 
of the same genes in other cell types.
Although selective smooth muscle IL-4R expression is 
sufficient for AHR induction by allergen or cytokine inhala-
tion, it is not required. This is consistent with the previous 
demonstration of AHR in transgenic mice that overexpress 
IL-13 in their lungs and express Stat6 only in airway epithelial 
cells (Kuperman et al., 2002). Most likely, AHR can be in-
duced in mice either by airway narrowing caused by epithe-
lial cell enlargement and mucus production, despite normal 
affinity of intestinal smooth muscle for acetylcholine (Kellner 
et al., 2007), that IL-4 and IL-13 increase intestinal smooth 
muscle  responses  to  nerve  stimulation  through  a  Stat6- 
dependent mechanism (Zhao et al., 2003), that IL-13 acts in 
vitro to increase airway smooth muscle contractility and 
proliferation and stimulate smooth muscle production of the 
chemokine eotaxin (Shore, 2004b), and that IL-13 induces 
calcium transients in cultured mouse airway smooth muscle 
cells and augments the calcium and contractile responses of 
these cells to leukotriene D4 (Eum et al., 2005). However, 
until now, there has been no evidence that direct effects of 
IL-4/IL-13 on smooth muscle contribute to AHR develop-
ment in vivo.
Our results indicate that the direct effects of these cyto-
kines on smooth muscle contribute to AHR and are likely to 
be biologically important. In contrast to IL-4R–deficient 
mice, transgenic mice that express IL-4R only on smooth 
muscle cells and at approximately the same level as mice that 
have a single allele of the wild-type IL-4R gene developed 
AHR after i.t. inoculation with IL-4 or IL-13. This was ob-
served despite the lack of development of airway eosinophilia 
or goblet cell hyperplasia in the smooth muscle–only mice. 
Consistent results were observed after i.t. inoculation of dust 
mite allergen instead of IL-4 or IL-13. However, allergen 
administration  induced  less AHR  in  smooth  muscle–only 
mice than in wild-type mice, probably because endogenous 
Figure 8.  House dust mite allergen in-
duces allergic airway disease in mice that 
selectively lack IL-4R in smooth muscle. 
(A, top) Mice of the indicated genotype were 
inoculated i.t. with saline or 50 µg house dust 
mite allergen thrice weekly for 3 wk and then 
analyzed for AHR by barometric plethysmog-
raphy (one experiment, n = 5–8/group).  
(bottom) Mice were then inoculated with an 
additional dose of house dust mite allergen 
and analyzed for AHR with a flexiVent appara-
tus (one experiment, n = 5–8/group). (B and 
C) Percentage of PAS+ bronchial epithelial 
cells (B; one experiment, n = 5–8/group) and 
BAL cell numbers and differential counts (C; 
one experiment, n = 5–8/group). (D) Serum 
IgE levels evaluated by ELISA (one experiment, 
n = 5–8/group). Error bars indicate SEs. Aster-
isks indicate a significant increase (*, P < 0.05) 
for IL-13 versus saline treatment. All data were 
obtained from the same set of mice. Similar 
results were observed in a second experiment.JEM VOL. 208, April 11, 2011 
Article
863
Second, do IL-4/IL-13 effects on smooth muscle and epi-
thelial cells totally account for AHR induction by these cyto-
kines, or might effects of these cytokines on other non–bone 
marrow–derived cell types (neurons, fibroblasts, and vascu-
lar endothelium) also contribute? Mice that express a floxed 
IL-4R gene and both smooth muscle– and epithelial cell– 
specific Cre are currently being bred to address this question.
MATERIALS AND METHODS
Mice. BALB/c female wild-type and IL-4R–deficient mice were pur-
chased from Taconic. Rosa-YFP mice were purchased from the Jackson Lab-
oratory (Druckenbrod and Epstein, 2005). SMP8-Cre transgenic mice on a 
mixed genetic background were a gift from T. Clemens and J. Fagin (University 
of Cincinnati, Cincinnati, OH). These mice were bred to Rosa-YFP mice so 
that Cre expression could be localized by fluorescence microscopy. SMP8-
Cre mice were also bred to IL-4R/ mice to generate IL-4R//
SMP8–IL-4R+/ mice, which were then bred to IL-4Rflox/flox mice to 
generate SMP8-Cre+//IL-4Rflox/ mice, which selectively delete IL-4R 
in smooth muscle cells. Because these mice have a mixed genetic background, 
littermates that had an SMP8-Cre//IL-4Rflox/ genotype (designated, for 
the sake of simplicity, as IL-4R+/ mice) were used as controls, as were mixed 
genetic background IL-4R/ mice. A PCR approach was used for geno-
typing. All animal experiments were approved by the Cincinnati Children’s 
Hospital Medical Center Institutional Animal Care and Use Committee.
Immunological reagents. M1 (rat IgG2a anti–mouse IL-4R mAb; 
Beckmann et al., 1990) was originally obtained from K. Grabstein (Amgen) 
and was grown as ascites in Pristane-primed athymic nude mice and purified 
by ammonium sulfate fractionation and DE-52 cation exchange chromatog-
raphy. GL117, a control rat IgG2a (anti–Escherichia coli -galactosidase) was 
obtained from DNAX and purified in the same way. mAbs were labeled with 
biotin. Fluorochrome-labeled mAbs to CD4, B220, and CD45 were pur-
chased from BD. Dust mite allergen was purchased from GREER.
Construction of an SMP8–IL-4R fusion gene. We constructed a 
fusion gene in which IL-4R cDNA was controlled by smooth muscle–
-actin regulatory sequences. IL-4R cDNA (Mosley et al., 1989; a gift from 
Amgen) had previously been placed upstream of the terminal SV40 T-antigen 
intron and polyA signal sequence in a pUC18-based plasmid controlled by 
the FABPi promoter. The FABPi promoter was excised by digestion with 
NdeI followed by a partial BamHI digest, which produced a 5.8-kb pro-
moterless fragment containing IL-4R cDNA upstream of the SV40 T-intron 
and polyA signal in a pUC18 backbone. A 3.6-kb NdeI–BamHI fragment 
containing 1,074 bp of the 5 flanking region, 63 bp of 5 untranslated, and 
the 2.5-kb first intron of smooth muscle–-actin was released from pSMP8-
CAT (Qian et al., 1999), ligated to the IL-4R–polyA-pUC18 fragment, and 
transformed  into  E.  coli TOP  10  cells  using  standard  protocols.  Selected 
clones were PCR screened using sense SMP8 primer 5-GCCTGTGA-
CACTCCCGCT-3 located within intron 1 and antisense IL-4R primer 
5-TCAGAGAAGCAGGTGGGC-3 located 92 bases within the IL-4R 
coding sequence. The veracity of the junctions in the pUC18-SMP8up– 
IL-4R–SV40TpolyA construct was confirmed by sequencing across the li-
gation junction of selected clones.
Generation of SMP8–IL-4R transgenic mice. An NdeI–Not1 digest 
of pUC18-SMP8up–IL-4R–SV40TpolyA liberated a 7.5-kb linear frag-
ment that was gel-purified for pronuclear microinjection by the Cincinnati 
Children’s Hospital Medical Center Transgenic Mouse Core. The transgenic 
founder animals were generated on an FVB/N genetic background. The off-
spring generated after pronuclear microinjection were typed by PCR analysis 
of tail DNA using the sense SMP8 and antisense IL-4R primers described 
in the previous section and verified by Southern blot using a BamHI   
IL-4R–SV40TpolyA fragment as probe (Horsnell et al., 2007). Offspring 
that were both PCR- and Southern blot–positive were bred to BALB/c   
smooth muscle contractility, or by increased smooth muscle 
contractility, despite normal airway diameter. Alternatively, it 
is possible that IL-4/IL-13 effects on airway epithelium indi-
rectly increase smooth muscle contractility.
The significance of AHR in rodents and the best way to 
determine it has been debated (Finkelman, 2008). There are 
considerable differences between murine and human lung 
structure, and it is impossible to characterize maximal volun-
tary inhalations and exhalations in rodents (these are used to 
measure airway responsiveness in people). Noninvasive tech-
niques performed with awake mice, such as barometric pleth-
ysmography, avoid changes in airway physiology that are 
induced by anesthesia and intubation but are indirect and can 
be influenced by upper airway inflammation and factors other 
than airway diameter and distensibility. Invasive techniques 
allow more direct measurement of airway characteristics, but 
the results they provide may be distorted by instrumentation 
and the use of anesthetics and paralytics. We approached the 
issues raised by these considerations by using three different 
techniques to measure responsiveness to cholinergic stimula-
tion. Despite their differences, each technique demonstrated 
that exogenous and endogenously produced IL-4/IL-13 in-
duce AHR in mice that express IL-4R only on smooth 
muscle cells but not in fully IL-4R–deficient mice.
This still leaves open the issue of whether our results with 
mouse models are applicable to human asthma. Although it is 
impossible to resolve this issue without performing human 
studies that are unethical and probably technically impossible, 
similar in vitro observations made with IL-4/IL-13–stimulated 
rodent and human smooth muscle cells (Shore, 2004a,b) make 
it seem likely that the in vivo mouse observations will also 
extend to humans. Indeed, the much greater airway diameter 
in humans than in mice and the development of considerable 
smooth muscle hyperplasia by human asthmatics (Ebina et al., 
1993) but not by mice in our study make it likely that effects 
of IL-4/IL-13 on smooth muscle contribute more to AHR in 
human asthma than in our mouse models. In this regard, our 
model in which AHR depends directly on IL-4/IL-13 effects 
on smooth muscle should be useful for evaluating potential 
therapeutics for human asthma.
Two other issues raised by our observations remain unre-
solved and are attractive subjects for future study. First, why do 
IL-4 and IL-13 differ in their relative effects on airway respon-
siveness in IL-4R+/ versus IL-4R//SMP8–IL-4R+/ 
mice? One possible explanation is that IL-4 but not IL-13 stim-
ulates NK and T cells to produce IFN- and IL-10 (Finkelman 
et al., 2005; Morris et al., 2006; unpublished data), cytokines 
which can suppress airway responsiveness. Failure of IL-4 to 
induce these cytokines in IL-4R//SMP8–IL-4R+/ mice 
might account for the greater IL-4 stimulation of AHR in 
IL-4R//SMP8–IL-4R+/ mice than IL-4R+/ or wild-
type mice. The failure of IL-13 to induce IFN- or IL-10 ex-
pression would account for the greater effect of IL-13 on AHR 
in wild-type mice, in which it directly affects epithelial and 
inflammatory cells, than on IL-4R//SMP8–IL-4R+/ 
mice, in which it only directly affects smooth muscle.864 Smooth muscle IL-4R–dependent AHR | Perkins et al.
and a Max II apparatus for analyzing barometric plethysmography (Buxco 
Research  Systems).  Baseline  measurements  of  enhanced  pause  (Penh; 
Hamelmann et al., 1997) were made over a 5-min period. Mice were then 
challenged for 3 min by inhalation of aerosolized -methacholine in PBS, 
produced with a nebulizer (model 5500D-030; DeVilbiss Healthcare), start-
ing at a methacholine concentration of 0.8 mg/ml. Penh measurements were 
made for 5 min, starting 2 min after completion of exposure to the aerosol-
ized methacholine, and average Penh values for the 5-min period were cal-
culated. The  procedure  was  then  serially  repeated  with  methacholine  at 
concentrations of 1.6, 3.2, 6.4, 12.8, and 25.6 mg/ml. Airway responsiveness 
of anesthetized, intubated mice to acetylcholine by the APTI technique was 
performed as previously described (Gavett et al., 1994). Airway responsive-
ness of anesthetized, intubated mice to methacholine was also performed 
with a flexiVent apparatus (SCIREQ). Mice were anesthetized with xylazine 
and Na pentobarbital. Their tracheas were then cannulated with an 18-gauge 
needle, and mice were ventilated at 150 breaths/min, 3.0-cm water positive 
end expiratory pressure. Mice were paralyzed with pancuronium bromide 
(Sigma-Aldrich) and allowed to stabilize on the ventilator for 2 min. Two 
total lung capacity perturbations were performed for airway recruitment 
before baseline measurement and subsequent methacholine challenges were 
performed. Dynamic resistance (R) was determined by fitting the data to a 
single compartment model of airway mechanics where Ptr = RV + EV+ PO 
(Ptr, tracheal pressure; V, volume; and PO, constant). Resistance measurements 
were made using a 1.25-s, 2.5-Hz volume driven oscillation applied to the 
airways by a computer-controlled piston (SnapShot perturbation). Metha-
choline was aerosolized for 10 s followed by 10 s of ventilation with an ultra-
sonic nebulizer (Aeroneb; Aerogen), and 20 SnapShot perturbations were 
performed. The procedure was repeated for 0, 6.25, 25, and 100 mg/ml con-
centrations of methacholine. The maximum R value with a coefficient of 
determination of 0.9 or greater (as determined by the flexiVent software) was 
used to determine the dose–response curve.
Lung histology. After BAL, lungs were inflated by injecting 1 ml of zinc 
formalin fixative through the catheter used to perform BAL. Lungs were 
then removed and fixed in the same solution. Lung sections were stained 
with periodic acid-Schiff (PAS) and examined microscopically.
Evaluation of goblet cell hyperplasia. Lung sections stained with PAS were 
evaluated blindly. Three bronchioles containing 90–130 epithelial cells were 
identified on each section. PAS+ (goblet) cells and total epithelial cell nuclei per 
bronchiole section were counted, and the ratio was converted into a percentage.
Preparation of suspensions of tracheal smooth muscle cells. Tracheas 
excised from mice were rinsed in antibiotic-supplemented HBSS. Connec-
tive tissue was removed under a dissecting microscope. Tracheas were then 
flushed with 0.02% EDTA and cut longitudinally. The tracheal interior was 
scraped with a round scalpel blade, and the trachea was transferred to a Petri 
dish containing 2 ml HBSS and 20 µl each of Liberase Blendzyme 1 and 4 
(Roche). Tissue was incubated for 20 min at 37°C in an atmosphere that 
contained 5% CO2. Dissociated tissue was further cleaned, and tracheal rings 
were separated into smaller tissue fragments. Three tissue fragments of 2–3 mm2 
were transferred, intima side down, to collagen IV–coated Petri dishes (BD). 
The plates were prewetted with smooth muscle basal medium containing 
growth supplements human epidermal growth factor, insulin, human fibro-
blast growth factor B, FBS, and GA-1000 (Lonza). Additional media was 
added to the plate to just cover the tissue. The plates were incubated at 37°C, 
5% CO2 for 4 d undisturbed to allow the tissue to become established to the 
collagen. Enough media was added for the first 10–14 d to just keep the tissue 
covered. After 10–14 d of incubation and observing growth of new smooth 
muscle cells, media was gently pipetted off and replaced with enough new 
media to just cover the tissue. Media was replaced every 4 d thereafter. Cells 
were lifted from the plate and stained after 2–3 wk of growth.
Preparation of suspensions of tracheal epithelial cells. Epithelial cells were 
isolated from mouse tracheas by enzymatic digestion with 0.1% Pronase (Roche). 
IL-4R–deficient mice, and their progeny were screened by PCR for the 
presence  of  the  SMP8up–IL-4R–SV40TpolyA  transgene. Transgene-
positive offspring were bred a second time to BALB/c IL-4R–deficient 
mice to generate F1 double backcross offspring that were typed by PCR for 
the presence of the transgene, using sense SMP8 and antisense IL-4R prim-
ers, and for the absence of the normal IL-4R gene using primers to neo-
mycin  (Neo  forward,  5-AGACAATCGGCTGCTCTGAT-3;  and  Neo 
reverse, 5-ATACTTTCTCGGCAGGAGCA-3) and IL-4R exon 7 (Ex7 
forward,  5-CATATGTCCCTGTCTTCCTT-3;  and  Ex7  reverse,  5-GGA-
CTCCACTCACTCCAG-3), which was deleted during the generation of 
IL-4R–deficient mice. We verified expression of the transgene in RNA 
isolated from uterus (which is rich in smooth muscle) and gut by RT-PCR 
using  sense  primer  SMP8  exon  1  5-GGACACCACCCACCCAGA-3 
combined with antisense IL-4R primer, resulting in a 158-bp amplicon 
specific to SMP8–IL-4R messenger RNA.
IL-4–anti–IL-4 complexes. To extend the in vivo half-life of IL-4, mice 
were inoculated in some experiments with complexes produced by mixing 
recombinant mouse IL-4 with a neutralizing anti–IL-4 mAb (BVD4-1D11) 
at a 2:1 molar (1:5 weight) ratio, which saturates the mAb with IL-4. We have 
previously demonstrated that these complexes have an in vivo half-life of 
1 d and slowly dissociate, releasing biologically active IL-4 (Finkelman et al., 
1993). Because these complexes contain a single IgG molecule, they nei-
ther fix complement nor react more avidly than uncomplexed serum IgG 
with FcRs. Because IL-4 cannot bind to IL-4Rs when it is complexed with 
BVD4-1D11, there is no possibility for these complexes to cross-link IL-4Rs 
to FcRs. Uncomplexed IL-4 has similar effects as IL-4C on lung inflamma-
tion and airway responsiveness, but higher quantities are required to obtain 
the same effect (Finkelman et al., 1993).
In vivo cytokine production. IL-4 production was measured with the in 
vivo cytokine capture assay (Finkelman et al., 2003). Mice were injected with 
10 µg biotin-anti–IL-4 mAb and bled 1 d later, and serum levels of IL-4–biotin-
anti–IL-4 mAb complex were determined. Serum levels of IL-13–sIL-13R2 
complex were measured as described previously (Khodoun et al., 2007).
i.t. inoculation. Mice were anesthetized by i.p. injection of ketamine and 
xylazine and allowed to hang vertically with their mouths open, supported by 
a taut string placed under their canine teeth. Their tongues were gently with-
drawn with a blunt forceps to keep them from swallowing, and 40 µl of vehi-
cle (1% autologous serum in PBS) ± IL-4C was pipetted onto the base of the 
tongue. When the mice had aspirated the pipetted solution, they were placed 
on their sides in a box flushed with 100% oxygen until they recovered from 
the anesthesia.
BAL. Mice were sacrificed, and polyethylene catheters (OD = 0.97 mm; 
BD) were inserted into their tracheas. Lungs were lavaged three times with   
1 ml Ca2+- and Mg2+-free HBSS (Invitrogen), which contained 0.02% EDTA 
and EGTA. The BAL fluid was centrifuged at 1,000 rpm for 5 min at 4°C. 
Cell pellets were resuspended in 1.5 ml cold HBSS with 10% newborn bovine 
serum and 0.2% NaN3 (HNA) and counted with a Beckman Coulter coun-
ter. 200,000 cells were centrifuged at 700 rpm for 5 min onto glass micro-
scopic slides with a cytocentrifuge (Shandon Scientific). Slides were stained 
with Giemsa stain (Sigma-Aldrich). At least 200 cells/slide were examined 
microscopically and characterized as neutrophils, lymphocytes, macrophages, 
or eosinophils.
Inoculation protocol. Mice were inoculated i.t. with saline, IL-4C (2 µg 
IL-4/10 µg anti–IL-4 mAb) every other day for 7 d, IL-13 (2 or 3 µg) daily 
for 7 d, or with dust mite allergen, 50 µg three times per week for 3 wk.
Determination of airway responsiveness to methacholine. For deter-
mination of responsiveness to methacholine by barometric plethysmography, 
mice  were  placed,  unrestrained,  in  cylindrical  Plexiglas  plethysmograph 
chambers that were connected to a nebulized control aerosol delivery system JEM VOL. 208, April 11, 2011 
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Detached cells were suspended in bronchial epithelial cell growth medium 
(Lonza) and plated on Transwell plates (Corning) that had been coated with 
collagen type 1 (BD) at 1 mg/ml. Cultures were grown at 37°C in a 5% 
CO2–containing atmosphere until the cells became confluent. Cells were 
then dissociated from the plates with Liberase (Roche) and analyzed for sur-
face IL-4R expression by flow cytometry.
Fluorescence microscopy. Frozen sections of lung and jejunum were pre-
pared, mounted with Vectashield mounting medium with DAPI, and exam-
ined for background and YFP fluorescence with a microscope (Axioskop; 
Carl Zeiss) equipped with filters for  YFP (EX 513 and EM 527). Photographs 
were taken with a color camera (MRC 5; Carl Zeiss) and processed with   
Axiovision software version 4.3 (Carl Zeiss) and Photoshop CS (Adobe).
Gene expression experiments. Gene expression of homogenized whole 
lung was determined by a gene scan approach, as previously described (Lewis 
et al., 2009; GEO DataSets accession no. GSE26476). Gene scan results were 
confirmed  by  real-time  PCR,  as  previously  described  (Finkelman  et  al., 
2005), using primers purchased from QIAGEN. IL-13–responsive genes were 
considered to be induced predominantly or entirely in smooth muscle cells if 
they were (a) expressed less in IL-13–inoculated SMP8-Cre+//IL-4Rflox/ 
mice than in IL-13–inoculated IL-4R+/ mice and (b) expressed no more 
in IL-13–inoculated SMP8-Cre+//IL-4Rflox/ mice than in saline-inoculated 
SMP8-Cre+//IL-4Rflox/ mice and/or were expressed no more in IL-13–
inoculated  SMP8-Cre+//IL-4Rflox/  mice  than  in  IL-13–inoculated   
IL-4R/ mice.
Statistics. Data were analyzed with a one-tailed Student’s t test to test hy-
potheses that cytokine or allergen treatment increased AHR or did not increase 
goblet  cell  hyperplasia  or  airway  eosinophilia  in  IL-4R//SMP8– 
IL-4R+/ mice or induced all three effects in SMP8-Cre/IL-4Rflox/ mice.   
A one-tailed Student’s t test was also used to test the hypothesis that IL-13 
inhalation increased the expression in IL-4R//SMP8–IL-4R+/ mice 
but not in SMP8-Cre/IL-4Rflox/ mice of six genes that had previously 
been identified by a gene scan. IL-4R+/ and IL-4R/ were used as 
positive or negative controls, respectively.  Values for P < 0.05 were considered 
significant. Figures show means ± SEs.
Online supplemental material. Fig. S1 demonstrates that the SMP8-Cre 
transgene is expressed only in smooth muscle in arteries and intestine. On-
line supplemental material is available at http://www.jem.org/cgi/content/ 
full/jem.20100023/DC1.
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